 |
|
 |
 |
|
||||||||||||||
|
France to Reimburse only Obese Patients with type 2 Diabetics for Acomplia March 22, 2007 France will now reimburse only obese people with type-2-diabetics for buying diet drug Acomplia, and that too, not even the full amount. They will be eligible for only 35 percent of the amount. According to Sanofi, reimbursement for Acomplia in France is only for obese patients with type 2 diabetes whose disease are not properly treated by the standard diabetic drugs like sulfonylurea or metformin. Sanofi said these conditions were published in official journal and according to it; doctors must first try other diabetic treatments available and must put the patient on a special diet program and physical workouts. This reimbursement condition is seen as a major blow to Sanofi, who had similar setback in Germany too, where its application for reimbursement of Acomplia was totally rejected. However, the firm said Acomplia
will be available in France for 71.63 euros, including tax, for
28-days. |
||||||||||||||
